PL2021358T3 - Modyfikowane bakteriocyny i sposoby ich stosowania - Google Patents

Modyfikowane bakteriocyny i sposoby ich stosowania

Info

Publication number
PL2021358T3
PL2021358T3 PL07797461T PL07797461T PL2021358T3 PL 2021358 T3 PL2021358 T3 PL 2021358T3 PL 07797461 T PL07797461 T PL 07797461T PL 07797461 T PL07797461 T PL 07797461T PL 2021358 T3 PL2021358 T3 PL 2021358T3
Authority
PL
Poland
Prior art keywords
bacteriocins
modified
methods
bacteria
receptors
Prior art date
Application number
PL07797461T
Other languages
English (en)
Inventor
David W Martin Jr
Andrew C Jamieson
Dean M Scholl
Steven R Williams
Original Assignee
Avidbiotics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidbiotics Corp filed Critical Avidbiotics Corp
Publication of PL2021358T3 publication Critical patent/PL2021358T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
PL07797461T 2006-05-15 2007-05-14 Modyfikowane bakteriocyny i sposoby ich stosowania PL2021358T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74729906P 2006-05-15 2006-05-15
EP07797461A EP2021358B1 (en) 2006-05-15 2007-05-14 Modified bacteriocins and methods for their use
PCT/US2007/068908 WO2007134303A2 (en) 2006-05-15 2007-05-14 Modified bacteriocins and methods for their use

Publications (1)

Publication Number Publication Date
PL2021358T3 true PL2021358T3 (pl) 2012-09-28

Family

ID=38694773

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07797461T PL2021358T3 (pl) 2006-05-15 2007-05-14 Modyfikowane bakteriocyny i sposoby ich stosowania

Country Status (11)

Country Link
US (1) US7732586B2 (pl)
EP (2) EP2371842B1 (pl)
JP (1) JP5603070B2 (pl)
AT (1) ATE551354T1 (pl)
AU (1) AU2007249199B2 (pl)
BR (1) BRPI0711969A2 (pl)
CA (1) CA2652450C (pl)
DK (2) DK2371842T3 (pl)
ES (2) ES2548392T3 (pl)
PL (1) PL2021358T3 (pl)
WO (1) WO2007134303A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1946768A4 (en) * 2005-10-28 2009-11-11 Meiji Seika Kaisha OUTER COAT PROTEIN PA5158 OF PSEUDOMONAS AERUGINOSA
US8445639B2 (en) 2006-05-15 2013-05-21 Avidbiotics Corporation Recombinant bacteriophage and methods for their use
US8680019B2 (en) * 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
AU2008287426B2 (en) * 2007-08-10 2014-06-26 Protelica, Inc. Universal fibronectin type III binding-domain libraries
US20110021414A1 (en) * 2007-10-24 2011-01-27 Texas A & M University System Chimeric Phage Tail Proteins and Uses Thereof
US9115354B2 (en) 2010-05-27 2015-08-25 Avidbiotics Corp. Diffocins and methods of use thereof
KR101955171B1 (ko) 2010-05-27 2019-03-06 사이포스 바이오사이언시스 인코포레이티드 디포신 및 그의 사용 방법
WO2011152899A1 (en) 2010-06-02 2011-12-08 Johns Hopkins University System and methods for determining drug resistance in microorganisms
WO2015022306A1 (en) 2013-08-12 2015-02-19 Dupont Nutrition Biosciences Aps Methods for classification of microorganisms from food products
GB201416788D0 (en) * 2014-09-23 2014-11-05 Univ Glasgow Therapeutic applications for pyocins
CA2964630A1 (en) * 2014-11-07 2016-05-12 Avidbiotics Corp. Monocins and methods of use
CA3069690A1 (en) 2017-07-12 2019-01-17 DDP Specialty Electronic Materials US, Inc. Compositions and methods for remediation of sulfate reducing prokaryotes
US11572595B2 (en) 2018-12-31 2023-02-07 Roche Molecular Systems, Inc. Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems
CN110129279B (zh) * 2019-04-24 2022-02-18 昆明理工大学 一种粪肠球菌噬菌体及其分离、纯化、富集和应用
KR20230013025A (ko) * 2020-04-07 2023-01-26 필럼 바이오사이언시스 인코포레이티드 엔테로신 및 이를 사용하는 방법
CN112083253B (zh) * 2020-09-18 2021-07-02 西南交通大学 一种直流下土壤电参量状态反演方法
WO2023178352A2 (en) * 2022-03-18 2023-09-21 Carnegie Mellon University Lysin and gp38 peptides for bacteria detection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4142939A (en) 1976-03-31 1979-03-06 Oregon State Board Of Higher Education, An Agency Of The State Of Oregon Method of producing an r-type bacteriocin and its use in the detection of specific microorganisms
US4861754A (en) 1986-05-28 1989-08-29 Farkas Himsley Hannah Bacteriocins and compositions thereof in anti-viral treatment
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
KR20010032432A (ko) 1997-11-25 2001-04-25 제너럴 하스피톨 코포레이션 균력 관련 핵산 서열 및 이의 용도
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
WO2000060070A1 (en) 1999-04-01 2000-10-12 Innogenetics N.V. A polypeptide structure for use as a scaffold
AU6027300A (en) * 1999-07-06 2001-01-22 Friesland Brands B.V. Methods and means for producing improved dairy products
US7034113B2 (en) 2002-02-22 2006-04-25 Paradigm Diagnostics, Llc Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
CA2541941C (en) 2003-10-06 2015-05-26 Gangagen, Inc. Anti-bacterial phage tail compositions and uses thereof
CN101090967A (zh) 2004-08-03 2007-12-19 加利福尼亚大学董事会 产多形性蛋白质序列的位点特异性系统
US20060229244A1 (en) * 2004-09-27 2006-10-12 Robert Dorit Engineered bacteriocins and bacteriocin combinations and methods for treating bacterial based infections

Also Published As

Publication number Publication date
EP2021358B1 (en) 2012-03-28
WO2007134303A3 (en) 2008-03-13
DK2371842T3 (en) 2015-10-26
EP2021358A2 (en) 2009-02-11
CA2652450A1 (en) 2007-11-22
ES2548392T3 (es) 2015-10-16
EP2371842B1 (en) 2015-07-22
DK2021358T3 (da) 2012-07-16
BRPI0711969A2 (pt) 2012-01-24
AU2007249199A1 (en) 2007-11-22
US7732586B2 (en) 2010-06-08
EP2371842A1 (en) 2011-10-05
CA2652450C (en) 2013-10-15
JP5603070B2 (ja) 2014-10-08
WO2007134303A2 (en) 2007-11-22
ES2387722T3 (es) 2012-09-28
US20080113406A1 (en) 2008-05-15
AU2007249199B2 (en) 2012-02-09
JP2009537146A (ja) 2009-10-29
ATE551354T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
PL2021358T3 (pl) Modyfikowane bakteriocyny i sposoby ich stosowania
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
MY156458A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
WO2006085938A3 (en) Il-13 binding agents
WO2011039510A3 (en) Conjugates targeting the cd163 receptor
IL246674B (en) Interleukin-13 antibody composition
EP1809326A4 (en) MODULATION OF ANTIBODY SPECIFICITY BY MEASURING ADAPTATION OF ITS AFFINITY TO AN APPARENT ANTIGEN
HRP20130400T1 (en) Anti-il-23 antibodies, compositions, methods and uses
WO2009035528A3 (en) Synthetic lipid a derivative
BR112013011193A2 (pt) bacteriófago p4 recombinante e métodos para seu uso
ZA200711073B (en) Anti-MCP-1 antibodies, compositions, methods and uses
EP2362862A4 (en) MODIFIED SULFUR BINDING AGENT AND METHOD OF PRODUCTION THEREOF, COMPOSITION COMPRISING HYDRAULIC MODIFIED SULFUR COMPOSITION, AND METHOD OF PREPARING THEREOF OR COMBUSTIBLE MODIFIED SULFUR COMPOSITION, AND PRODUCTION PROCESS THEREOF, CONTAINING THE MODIFIED SULFUR BINDING AGENT
IL206036A0 (en) ANTIBODIES TO THE PcrV ANTIGEN OF PSEUDOMONAS AERUGINOSA AND USES THEREOF
WO2008150530A3 (en) Cripto binding molecules
JP2008542528A5 (pl)
WO2009055074A8 (en) Erbb2 binding proteins and use thereof
WO2007030761A3 (en) Acyclic 1,4-diamines and uses thereof
EP1934318A4 (en) TRACTION FLUID COMPOSITION
WO2007144778A3 (en) Herbal compositions for the prevention or treatment of a urinary tract infection
EP1860182A4 (en) METHOD FOR REGENERATING ELASTIC FIBERS USING DANCE OR AN IMPROVING FACTOR THEREOF
WO2009047462A9 (fr) Feuille de verre silico-sodo-calcique
EP1957629A4 (en) Multi-analyte affinity column
WO2006041808A8 (en) Tafi inhibitors and their use to treat pulmonary fibrosis
WO2009106258A8 (de) Herbizid-kombinationen enthaltend diflufenican
WO2008083191A3 (en) Radiofluorination methods